Navigation Links
The QIAGEN Guide to Animal Cell Culture

Part II: Safety and handling considerations for animal cell culture

Welcome to the second of a new series of articles aimed at providing useful hints for culturing animal cells. This article describes considerations for working with animal cell cultures as well as information on cell culture contamination. The series will continue in future issues of QIAGEN News with information on cell culture growth conditions, followed by cell culture protocols.

Legislation and regulatory guidelines

Before undertaking any work with human or animal tissue (e.g., to establish a primary cell culture), it is necessary to ensure that the nature of the work conforms to the appropriate medical-ethical and animal-experiment legislation and guidelines. It may be necessary to seek approval from the relevant regulatory authorities and/or individuals.

Safety considerations and biohazards

When working with potentially hazardous material, it is important to be aware of the possible risks associated with both the material and the experimental protocol. All cell cultures are considered a biohazard because of their potential to harbor an infectious agent (e.g., a virus). The degree of hazard depends on the cells being used and the experimental protocol. Primary cell cultures in particular should be handled carefully as these cultures have a high risk of containing undetected viruses. Although commonly used cell lines are generally assumed to be free of infectious agents, care should still be exercised when working with these cell lines as it is possible that they contain infectious agents, such as latent viruses. Cell cultures used to stud
'"/>

Source:


Page: All 1 2 3 4 5 6

Related biology technology :

1. The QIAGEN Guide to Animal Cell Culture
2. The QIAGEN Guide to Animal Cell Culture
3. The QIAGEN Guide to Animal Cell Culture
4. The QIAGEN Guide to Animal Cell Culture
5. The QIAGEN Guide to Animal Cell Culture
6. QIAGEN Instrument Service insist on the best in service and support
7. QIAGEN Multiplex PCR Handbook
8. QIAGEN Multiplex PCR Kit
9. QIAGEN Plasmid Kits
10. Laser microdissection and nucleic acid purification - a Leica - QIAGEN cooperation
11. QIAGEN PCR CloningPlus Kit

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The QIAGEN Guide Animal Cell Culture

(Date:11/9/2009)...NDON, November 9 Following the pro...ood and Drug Administration (FDA), privately,owned...ww.davalinternational.com ) has been informed that... has been awarded an Orphan-Drug,designation for t...). , ALS, also known as Lou Gehrig,s dise...
(Date:11/8/2009)...NTAIN VIEW, Calif. Nov. 5, 2009 Complete Genomic...any, today announced publication of a report in th... sequencing platform, including analysis of sequen...sumables cost for these three genomes sequenced on...ged from $8,005 for 87x coverage to $1,726 for 45x...
(Date:11/6/2009)...O, Nov. 6 /PRNewswire-FirstCall/ - Microbix Biosys...has re-filed the Form 52-109F1 Certification of An...e Officer and James Long, the Chief Financial Offi...2, 2009 in connection with the annual audited fina...2008. ,, The Company initially filed the annual...
(Date:11/6/2009)..., Ontario, Nov. 6 Helix ...BPF) today announced that John Docherty, president...iman Curhan Ford,s 6th annual Investor Summit on N...n New York City. Mr. Docherty will provide an ove... programs L-DOS47 and Topical Interferon Alpha-2b....
Breaking Biology Technology:Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3
...0 split ratio, SEATTLE, Aug. 25 Cell Therapeutic...t its Board of Directors has,authorized a 1-for-10...lit,will become effective as of August 31, 2008., ...of Annual Meeting of,Shareholders held on June 19,...ze the Board, in its discretion, to effect a rever...
...kman,Coulter, Inc. (NYSE: BEC ), a leading develo...implify, automate, and innovate complex biomedical...kman Coulter,s senior vice,president and chief fin...Healthcare Conference 2008 on Thursday, September ...wscom.com/cgi-bin/prnh/20031202/BECLOGO ), The li...
...nd business expertise, SCOTTSDALE, Ariz., Aug. 22...company that markets the Provant(R) Wound Therapy,...s to its Board of,Directors. The two new directors...harmaceuticals, and Charles "Chuck" S. Lunden, a p...://www.newscom.com/cgi-bin/prnh/20080422/LATU008 )...
Other Biology Technology:Cell Therapeutics, Inc. Announces Reverse Stock Split 2Regenesis Biomedical Announces Additions to Board of Directors 2
(Date:11/6/2009)... generally live in harmony with their arboreal hos...ut of space in their trees of choice, the ants can...earch, published in the November issue of the Ame...nts bore into live trees, and it reopens a centuri... plants. , Ants and certain species of plants an...
(Date:11/5/2009)...searchers at Yale University have developed synthe...ne response to HIV and HIV-infected cells, as well...ished online in the Journal of the American Chemi...oaches for these diseases. , The molecules cal...ARM-H) and "antibody-recruiting molecule targeting...
(Date:11/4/2009)...idors in the cities of Long Beach and Riverside ar...entable childhood asthma, and the true impact of a... likely been underestimated, according to research.... , The study, which appears in an online editi...imated that nine percent of all childhood asthma c...
Breaking Biology News(10 mins):Ants are friendly to some trees, but not others 2New synthetic molecules trigger immune response to HIV and prostate cancer 2USC study finds big air pollution impacts on local communities 2Kaiser Workers Statewide Campaign Starts Tuesday 55751 1Kaiser Workers Statewide Campaign Starts Tuesday 55751 2CPF Submits Comments to CMS to Save Only Effective Therapy Available to PF Patients 55748 1CPF Submits Comments to CMS to Save Only Effective Therapy Available to PF Patients 55748 2CPF Submits Comments to CMS to Save Only Effective Therapy Available to PF Patients 55748 3CPF Submits Comments to CMS to Save Only Effective Therapy Available to PF Patients 55748 4CPF Submits Comments to CMS to Save Only Effective Therapy Available to PF Patients 55748 5VirtualScopics to Present at the Rodman 26 Renshaw Annual Global Investment Conference 55746 1VirtualScopics to Present at the Rodman 26 Renshaw Annual Global Investment Conference 55746 2
...E, Fla. Replacing one amino acid on the surface o...ls could be the breakthrough scientists have neede...eating genetic diseases such as hemophilia, Univer...he journal Proceedings of the National Academy of ...ave developed a new version of the adeno-associate...
...bout water quality at beaches along the Great Lake... waters are safe for recreation. A new collaborati...each managers when they are faced with deciding wh...his collaborative effort will draw on the expertis...te and local agencies. , The project has been fu...
...WA The inland areas of the Pacific Northwest, whe... present growing challenges for vineyard owners an...s part of the country have not been conducive for ...y wine grapes. , To promote healthy grape product...s in the area typically employ an irrigation pract...
Other Biology News:UF researchers develop improved gene therapy agent 2UF researchers develop improved gene therapy agent 3To swim or not to swim? 2Study results: new recommendations for grape growers 2
Rabbit Anti-Human PALLD Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Cloning and Expression Services from Molecular Biology Resources
Cat IgA ELISA Kit from Bethyl Laboratories
Ph.D.-C7C Disulfide Constrained Peptide Library Kit from New England Biolabs
Biology Products: